Newsroom | 5100 results

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...

CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced that its affiliated health care provider, WHOOP Physician Services, PC, was selected into the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s ACCESS program, a new initiative designed to expand access to high-quality, technology-enabled care for Medicare beneficiaries managing chronic conditions. Through this program, eligible Medicare beneficiaries will be able to receive WHOOP and its data-dr...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--El Camino Healthcare District launches free self-screening and dietitian program to help adults detect and reduce prediabetes risk....

COLUMBIA, Md. & BALTIMORE, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced a strategic partnership with b.well Connected Health, whose health data management platform powers the nation’s largest consumer-mediated health data network, connecting nearly 2.4 million providers and 350 health plans. Through this partnership, Welldoc gains access to patient-authorized health data at an unprecedented scale, enabling more complete, personalized i...

BOSTON--(BUSINESS WIRE)--The T1D Fund: A Breakthrough T1D Venture, LLC, an impact investment fund focused on accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes (T1D), today announced the appointment of Anastasia Bukhman, Co-Founder of the Bukhman Foundation, to its Board of Directors. “As both a major supporter of T1D innovation and a champion of international collaboration, Anastasia brings philanthropic leadership and valuable strategic perspective to...

WASHINGTON--(BUSINESS WIRE)--Today, the Obesity Care Advocacy Network (OCAN) released new survey data revealing strong demand among older Americans for Medicare coverage of FDA-approved obesity medications and a significant opportunity for Medicare Part D plans considering participation in the Centers for Medicare & Medicaid Services’ BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) Model. The national survey of more than 2,130 Americans age 65 and older highl...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Healthy Horizons in Ohio and CPESN USA launch value-based Pharmacist Quality Rewards program to improve chronic condition care....

DALLAS--(BUSINESS WIRE)--As demand for GLP-1 medications continues to surge across the U.S., accelerated by expanding clinical indications, more market entrants, and novel pricing and access models, new research suggests employer-sponsored health benefits may play a significant role in determining who ultimately uses these treatments. A national survey conducted by The Harris Poll on behalf of Wondr Health, the leading provider of behavioral weight management and GLP-1 clinical solutions, finds...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2026 financial results on Monday, May 4, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals First Quarter 2026 Earnings Call.” The conference call will be webcast live and a link to the webcast can be...